4.5 Article

Design, synthesis, and evaluation of novel N-l fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyrase

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 28, Issue 10, Pages 1903-1910

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2018.03.085

Keywords

Bacterial resistance; Fluoroquinolone; DNA gyrase; Topoisomerase

Funding

  1. National Institutes of Health (NIH) [R01 AI87671]
  2. NIH Predoctoral Training Program in Pharmacological Sciences [GM067795]
  3. American Foundation for Pharmaceutical Education Predoctoral Fellowship Program
  4. American Chemical Society Division of Medicinal Chemistry Fellowship
  5. University of Iowa Center for Biocatalysis and Bio-processing
  6. NIH [GM008365]

Ask authors/readers for more resources

Structural studies of topoisomerase-fluoroquinolone-DNA ternary complexes revealed a cavity between the quinolone N-l position and the active site tyrosine. Fluoroquinolone derivatives having positively charged or aromatic moieties extended from the N-l position were designed to probe for binding contacts with the phosphotyrosine residue in ternary complex. While alkylamine, alkylphthalimide, and alkylphenyl groups introduced at the N-l position afforded derivatives that maintained modest inhibition of the supercoiling activity of DNA gyrase, none retained ability to poison DNA gyrase. Thus, the addition of a large and/or long moiety at the N-l position disrupts ternary complex formation, and retained ability to inhibit supercoiling is likely through interference with the strand breakage reaction. Two derivatives were found to possess inhibitory effects on the decatenation activity of human topoisomerase II. (C) 2018 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity

Lisa M. Oppegard, Justine L. Delgado, Chaitanya A. Kulkarni, Tyrell R. Towle, Delaney E. Hart, Bridget P. Williams, Sarah R. C. Lentz, Beverly J. Norris, Craig M. Flory, Robert J. Schumacher, Daryl J. Murry, Robert J. Kerns, Hiroshi Hiasa

INVESTIGATIONAL NEW DRUGS (2019)

Article Biochemistry & Molecular Biology

Cellular Compartmentation and the Redox/Nonredox Functions of NAD+

Chaitanya A. Kulkarni, Paul S. Brookes

ANTIOXIDANTS & REDOX SIGNALING (2019)

Article Chemistry, Medicinal

Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone

Justine L. Delgado, Sarah R. C. Lentz, Chaitanya A. Kulkarni, Pratik R. Chheda, Hailey A. Held, Hiroshi Hiasa, Robert J. Kerns

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biology

ALKBH7 mediates necrosis via rewiring of glyoxal metabolism

Chaitanya A. Kulkarni, Sergiy M. Nadtochiy, Leslie Kennedy, Jimmy Zhang, Sophea Chhim, Hanan Alwaseem, Elizabeth Murphy, Dragony Fu, Paul S. Brookes

ELIFE (2020)

Article Biochemistry & Molecular Biology

Acid enhancement of ROS generation by complex-I reverse electron transport is balanced by acid inhibition of complex-II: Relevance for tissue reperfusion injury

Alexander S. Milliken, Chaitanya A. Kulkarni, Paul S. Brookes

REDOX BIOLOGY (2020)

Article Chemistry, Medicinal

Discovery of Halogenated Benzothiadiazine Derivatives with Anticancer Activity**

Bader I. Huwaimel, Myla Bhakta, Chaitanya A. Kulkarni, Alexander S. Milliken, Feifei Wang, Aimin Peng, Paul S. Brookes, Paul C. Trippier

Summary: Study investigated benzothiadiazine derivatives for CII inhibition and their impact on cancer cells, identifying compounds with greater antineoplastic effect in triple-negative breast cancer cells compared to clinical agents. No correlation found between cytotoxicity and CII inhibition, suggesting undefined mechanism of action for this scaffold.

CHEMMEDCHEM (2021)

Article Chemistry, Medicinal

A Novel Triphenylphosphonium Carrier to Target Mitochondria without Uncoupling Oxidative Phosphorylation

Chaitanya A. Kulkarni, Brian D. Fink, Bettine E. Gibbs, Pratik R. Chheda, Meng Wu, William Sivitz, Robert J. Kerns

Summary: The study identified an inert mitochondria-targeting carrier by modifying the structure of TPP+, which successfully eliminated uncoupling activity, prevented dissipation of mitochondrial membrane potential, and did not negatively affect cargo delivery to mitochondria.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Small molecule SWELL1 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes

Susheel K. Gunasekar, Litao Xie, Ashutosh Kumar, Juan Hong, Pratik R. Chheda, Chen Kang, David M. Kern, Chau My-Ta, Joshua Maurer, John Heebink, Eva E. Gerber, Wojciech J. Grzesik, Macaulay Elliot-Hudson, Yanhui Zhang, Phillip Key, Chaitanya A. Kulkarni, Joseph W. Beals, Gordon Smith, Isaac Samuel, Jessica K. Smith, Peter Nau, Yumi Imai, Ryan D. Sheldon, Eric B. Taylor, Daniel J. Lerner, Andrew W. Norris, Samuel Klein, Stephen G. Brohawn, Robert Kerns, Rajan Sah

Summary: SWELL1 channel modulators represent a novel therapeutic approach for treating Type 2 diabetes and associated liver steatosis by enhancing insulin sensitivity and secretion. These modulators improve SWELL1-dependent systemic metabolism and hold promise for future treatment of diabetes and nonalcoholic fatty liver disease.

NATURE COMMUNICATIONS (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Role of Acidic pH in Linking SIRT1 and Cardioprotective Metabolism

Chaitanya A. Kulkarni, Alexander S. Milliken, Paul S. Brookes

CIRCULATION RESEARCH (2019)

Article Pharmacology & Pharmacy

Effect of a mitochondrial-targeted coenzyme Q analog on pancreatic -cell function and energetics in high fat fed obese mice

Yumi Imai, Brian D. Fink, Joseph A. Promes, Chaitanya A. Kulkarni, Robert J. Kerns, William I. Sivitz

PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)

Article Pharmacology & Pharmacy

Metabolic effects of a mitochondrial-targeted coenzyme Q analog in high fat fed obese mice

Brian D. Fink, Deng Fu Guo, Chaitanya A. Kulkarni, Kamal Rahmouni, Robert J. Kerns, William I. Sivitz

PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)

Meeting Abstract Chemistry, Multidisciplinary

Novel quinolone-class antibiotics designed to overcome resistance to fluoroquinolones

Chaitanya Kulkarni, Tyrell Towle, Robert Kerns

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2016)

Article Pharmacology & Pharmacy

A Mitochondrial-Targeted Coenzyme Q Analog Prevents Weight Gain and Ameliorates Hepatic Dysfunction in High-Fat-Fed Mice

Brian D. Fink, Judith A. Herlein, Deng Fu Guo, Chaitanya Kulkarni, Benjamin J. Weidemann, Liping Yu, Justin L. Grobe, Kamal Rahmouni, Robert J. Kerns, William I. Sivitz

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)